obesity-995x60.png obesity-995x60.png

FEATURED ARTICLES

child getting vaccine-GettyImages-1678122790 Lessons In Pivoting From A Clinical Trial Launch In Uganda

Gates MRI researchers share how they navigated supply chain challenges, an Ebola outbreak, and evolving regional malaria vaccination strategies to successfully execute a malaria clinical trial in Uganda.

WHITE PAPERS AND CASE STUDIES

SERVICES AND PRODUCTS

People-focused, detail-driven (and award-winning!) support for participants, sites, and sponsors.

Scout’s patient concierge team manages payments, travel, and scheduling with precision and empathy—helping sites save time, build trust, and reduce dropouts.

Everything you need to manage patient payments, travel, and logistics is right at your fingertips. The Scout Portal serves as a secure, user-friendly patient portal for clinical trials, allowing participants and site staff to submit and track requests anytime, anywhere—from desktop to mobile and every screen in between.

Designed for users like you

Scout is available through multiple single sign-on (SSO) integrations, giving you seamless access from the systems you already use.

Getting to and from a clinical trial site shouldn’t be a hurdle.

Whether it’s arranging ground, air, or rail transportation, assisting with visas or accessibility, or securing short- or long-term housing—Scout’s patient travel services make participation easier from start to finish.

Scout delivers patient engagement solutions that keep participants involved in clinical trials while supporting sites, sponsors, and CROs.

With tools that manage payments, travel, and communication, we make it easy for participants to stay connected and confident throughout their trial journey.

Flexibility matters. Scout helps you plan hybrid and virtual meetings that connect global teams and keep every attendee engaged.

Whether in-person, online, or both, our hybrid meeting solutions for clinical trials make collaboration simple, secure, and human.

In today’s regulatory climate, ongoing discussion about FDA workload, funding constraints, and shifting review priorities have sparked anxiety across the biopharma industry — especially for sponsors preparing for key submissions like INDs or NDAs. At Veristat, our most recent interactions reflect continued responsiveness and constructive engagement from FDA.

NEWS